Taiwan · Delayed Price · Currency is TWD Yoda Pharmaceuticals Statistics
Total Valuation
TPEX:7829 has a market cap or net worth of TWD 3.65 billion. The enterprise value is 2.66 billion.
| Market Cap | 3.65B |
| Enterprise Value | 2.66B |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7829 has 79.39 million shares outstanding. The number of shares has increased by 85.50% in one year.
| Current Share Class | 79.39M |
| Shares Outstanding | 79.39M |
| Shares Change (YoY) | +85.50% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.76% |
| Owned by Institutions (%) | 0.00% |
| Float | 54.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.71 |
| P/TBV Ratio | 3.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.53 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.51 |
Financial Position
The company has a current ratio of 32.42, with a Debt / Equity ratio of 0.00.
| Current Ratio | 32.42 |
| Quick Ratio | 32.31 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -15,072.04 |
Financial Efficiency
Return on equity (ROE) is -50.58% and return on invested capital (ROIC) is -30.38%.
| Return on Equity (ROE) | -50.58% |
| Return on Assets (ROA) | -29.47% |
| Return on Invested Capital (ROIC) | -30.38% |
| Return on Capital Employed (ROCE) | -39.72% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 52.26 |
| 200-Day Moving Average | 51.96 |
| Relative Strength Index (RSI) | 45.05 |
| Average Volume (20 Days) | 142,748 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -391.87M |
| Pretax Income | -407.22M |
| Net Income | -407.22M |
| EBITDA | -389.41M |
| EBIT | -391.87M |
| Earnings Per Share (EPS) | -5.14 |
Balance Sheet
The company has 994.39 million in cash and 811,000 in debt, with a net cash position of 993.58 million or 12.52 per share.
| Cash & Cash Equivalents | 994.39M |
| Total Debt | 811,000 |
| Net Cash | 993.58M |
| Net Cash Per Share | 12.52 |
| Equity (Book Value) | 984.02M |
| Book Value Per Share | 12.38 |
| Working Capital | 967.81M |
Cash Flow
In the last 12 months, operating cash flow was -353.39 million and capital expenditures -389,000, giving a free cash flow of -353.78 million.
| Operating Cash Flow | -353.39M |
| Capital Expenditures | -389,000 |
| Depreciation & Amortization | 2.46M |
| Net Borrowing | -792,000 |
| Free Cash Flow | -353.78M |
| FCF Per Share | -4.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7829 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.50% |
| Shareholder Yield | -85.50% |
| Earnings Yield | -11.15% |
| FCF Yield | -9.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |